Formerly doing business as LumaDerm LLC., LumaMed LLC provides cancer visualization devices that enable âreal timeâ and âwide fieldâ imaging of cancer margins during surgery. The firm's approach is based on âPolarization Subtraction Imagingâ (PSI), a patented technology that provides rapid, intra-operative digital imaging of the surface of tissue excised during cancer surgery. The resolution of images produced rival those obtained from histopathology in recognizing features characteristic of cancer and normal tissue. PSI uses non-ionizing visible light and is safe for use in the operating room. This ability to see the cancer margins in an intra-operative setting has enormous value in areas where tissue conservation is critical, such as in breast cancer, Mohs surgery for skin cancer as well as in head & neck cancers. Real time margin control will also allow for comprehensive treatment thereby reducing or removing the need for repeat procedures. LumaMed LLC offers technology solutions for patients to get an evaluation of suspicious skin lesions. Solutons include PsiScan, a hand held imager that captures high resolution digital images of subsurface skin features in a non-invasive and painless manner; and Connect2Derm, a Web based picture archiving and communication system that allows physicians, assistants, nurses, and technicians to upload and store images captured by the PsiScan device for distant specialist evaluation and consultation. Using LumaMedâs patented technology, LumaScanâ¢, helps assure both surgeons and patients that âthey got it allâ during cancer surgery. LumaScan provides intraoperative ex-vivo tissue imaging potentially useful in many cancers, including Breast Conservation Surgery (BCS; lumpectomy), oral cancer and skin cancer. Incredibly, as many as one out of every three BCS patients will require a second operation to completely
